|
|
|
|
|
|
|
|
|
|
| You
are encouraged to distribute the up-to-date English-language
VIS (above) at the same time as the translation. |
|
| |
|
|
|
| Translations: Out-of-date |
|
|
|
| The translations for
some VISs on our website are from previously published English-language
versions that have since been updated. Unfortunately, IAC is not always
able to obtain translations as updates are issued. Please ensure that your
patients receive information consistent with the current English-language
version of
the following VISs. |
|
| TRANSLATIONS OF THE JULY 30, 2001 DTaP VIS |
|
| |
|
| These translations do not
contain the following CDC updates: |
|
| • |
|
The main change is in Section 4, which now mentions Tdap. |
|
|
|
| • |
|
The NVICP and VAERS web addresses have also been updated |
|
|
|
| • |
|
The mortality rate for tetanus in Section 1 changed from 1 out of
10, to 2 out of 10 cases. |
|
|
|
| • |
|
The date changed to 5/17/07. |
|
|
|
|
| TRANSLATIONS OF THE AUGUST 15, 1997 DTaP VIS |
|
| |
|
| These translations do not
contain the following CDC updates: |
|
| • |
|
Most of the changes to
this VIS relate to the current exclusive use of the acellular DTaP; the
previous VIS included the whole-cell DTP, which is no longer used in the
U.S. |
|
|
|
| • |
|
Rates of reactions
(problems) that might be expected following DTaP have been changed and
are generally lower that those following DTP. |
|
|
|
| • |
|
The new URL for the
National Injury Compensation Program is listed. |
|
|
| This page was reviewed on February 26, 2009 |
Immunization Action Coalition
IAC Home
